All News

Abuse inflicted during childhood is lasting. Remember that adult patients may be survivors of child abuse, which makes them at risk for being in abusive relationships and for abusing their own children.

The outcomes of infants with poor fetal growth are better than what has been historically reported, according to preliminary study results.

What is your diagnosis of this facial anomaly in a 24-week fetus?

Evidence indicates that angiogenic growth factors have an important role in fibroid pathophysiology, including abnormal vasculature and fibroid growth and survival.

Breast density laws ensure that women receive critical breast-health information, supporters say, but many of the laws broadly classify breast density and fail to account for varying levels of risk.

Teens who eat peanut butter and other nuts may be at lower risk of benign breast disease (BBD) as adults, according to a new report published in Breast Cancer Research and Treatment.

A new retrospective study published in Obstetrics & Gynecology shows that robotics don’t improve benign hysterectomy outcomes and, in fact, increase cost of the surgery.

Robotic-assisted laparoscopic myomectomy and abdominal myomectomy to manage uterine fibroids were equally effective in improving symptoms, but each procedure has its own benefits.

Clear, consistent steps for each specific surgical procedure should be adopted so that team members can become familiar with each procedure with repetition. Procedural steps for a robotic hysterectomy are shown in the video.

We all know that American healthcare technology is expensive. But is it worth it?

The Society of Maternal-Fetal Medicine on managing pregnant patients who have had gastric banding or gastric bypass surgery.

Electrosurgical instruments aid skilled surgeons in performing safe cutting-edge procedures.

New apps, hardware, and software bring powerful functions to patients and physicians.

The surgeon's guide to positioning, port placement, safety, efficiency, and payment.

Three surgeons discuss the pros and cons of the two methods.

Patient education handout for becoming pregnant after bariatric surgery

A plan for determining if intrauterine growth restriction is present, then monitoring and delivering when and how it's best for mother and infant.

Compared with hysterectomy, GNRHa is an effective treatment of uterine fibroids and has an equivalent effect on sexual function.

The actual measurements of the total and core diameters of laser fibers used for urological surgery do not conform to the advertised measurements, a new study found.

A new registry-based study sheds light on patient factors that may influence risk of breast cancer associated with use of postmenopausal hormone replacement therapy (HRT)-including race, weight, and breast density. Findings from the report, published in The Journal of the National Cancer Institute, suggest the greatest association between HRT use and breast cancer in women with low/normal body mass index (BMI) and extremely dense breasts.

In an update of its 2002 recommendation on use of medications for breast cancer risk reduction, the U.S. Preventive Services Task Force (USPSTF) is encouraging informed decision-making and cautioning against use of medications for prevention in women who are not at increased risk of the disease.

• Leading experts discuss the emergence of certified nurse midwives into mainstream obstetric care. • Has your practice implemented collaborative care practices?

For many physicians, no matter their specialty, the one thing that keeps them up at night is fear of medical malpractice lawsuits. Elisabeth Madden, partner at Lynch Gilardi and Grummer law firm in San Francisco, is an attorney with more than 20 years’ experience defending healthcare providers. In this article, based on a session at a recent conference for dermatologic surgeons, Ms. Madden explains some of the top ways surgeons can avoid medical malpractice lawsuits.

What is your diagnosis of this incidental finding during routine ultrasonography in a 15-week fetus?

The use of 40 Gy in 15 fractions over 3 weeks is as effective and causes less damage to nearby tissue than a higher total dose of radiotherapy for breast cancer.

The Food and Drug Administration’s (FDA) advisory committee cleared the way for the approval of pertuzumab (Perjeta) to treat patients before they have surgery to remove their HER2-positive tumors. If approved, pertuzumab would be the first neoadjuvant drug approval for any form of cancer. The drug was already approved by the FDA for treatment of late-stage breast cancer last year.

A new multicenter analysis shows that most deaths from invasive breast cancer occur in women who don’t get routine mammograms. The findings, published in Cancer, point to a need to encourage routine screening in women younger than age 50.